HEADER HYDROLASE/HYDROLASE INHIBITOR 23-MAR-05 1Z71 TITLE THROMBIN AND P2 PYRIDINE N-OXIDE INHIBITOR COMPLEX STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ALPHA-THROMBIN; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HIRUDIN IIIB'; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 8 ORGANISM_TAXID: 6421; SOURCE 9 OTHER_DETAILS: OCCURS NATURALLY IN MEDICINAL LEECH HIRUDO SOURCE 10 MEDICINALIS KEYWDS THROMBIN INHIBITOR COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.G.NANTERMET,C.S.BURGEY,K.A.ROBINSON,J.M.PELLICORE,C.L.NEWTON, AUTHOR 2 J.Z.DENG,T.A.LYLE,H.G.SELNICK,S.D.LEWIS,B.J.LUCAS,J.A.KRUEGER, AUTHOR 3 C.MILLER-STEIN,R.B.WHITE,B.WONG,D.R.MCMASTERS,A.A.WALLACE,J.J.LYNCH AUTHOR 4 JR.,Y.YAN,Z.CHEN,L.KUO,S.J.GARDELL,J.A.SHAFER,J.P.VACCA REVDAT 6 16-OCT-24 1Z71 1 REMARK LINK REVDAT 5 11-OCT-17 1Z71 1 REMARK REVDAT 4 13-JUL-11 1Z71 1 VERSN REVDAT 3 24-FEB-09 1Z71 1 VERSN REVDAT 2 14-JUN-05 1Z71 1 JRNL REVDAT 1 17-MAY-05 1Z71 0 JRNL AUTH P.G.NANTERMET,C.S.BURGEY,K.A.ROBINSON,J.M.PELLICORE, JRNL AUTH 2 C.L.NEWTON,J.Z.DENG,H.G.SELNICK,S.D.LEWIS,B.J.LUCAS, JRNL AUTH 3 J.A.KRUEGER,C.MILLER-STEIN,R.B.WHITE,B.WONG,D.R.MCMASTERS, JRNL AUTH 4 A.A.WALLACE,J.J.LYNCH JR.,Y.YAN,Z.CHEN,L.KUO,S.J.GARDELL, JRNL AUTH 5 J.A.SHAFER,J.P.VACCA,T.A.LYLE JRNL TITL P(2) PYRIDINE N-OXIDE THROMBIN INHIBITORS: A NOVEL JRNL TITL 2 PEPTIDOMIMETIC SCAFFOLD JRNL REF BIOORG.MED.CHEM.LETT. V. 15 2771 2005 JRNL REFN ISSN 0960-894X JRNL PMID 15911253 JRNL DOI 10.1016/J.BMCL.2005.03.110 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 31786 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3173 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2337 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 194 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.350 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Z71 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-05. REMARK 100 THE DEPOSITION ID IS D_1000032378. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32360 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : 0.04700 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.21900 REMARK 200 R SYM FOR SHELL (I) : 0.21900 REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8K, SODIUM PHOSPHATE, PH 7.3, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.98500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.74500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.98500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.74500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 14L REMARK 465 GLY A 14M REMARK 465 ARG A 15 REMARK 465 THR A 146A REMARK 465 TRP A 146B REMARK 465 THR A 146C REMARK 465 ALA A 146D REMARK 465 ASN A 146E REMARK 465 VAL A 146F REMARK 465 GLY A 146G REMARK 465 LYS A 146H REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 14K CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -86.55 -131.91 REMARK 500 TYR A 60A 84.12 -159.64 REMARK 500 ASN A 60G 73.73 -158.15 REMARK 500 HIS A 71 -59.40 -134.16 REMARK 500 ILE A 79 -57.79 -129.41 REMARK 500 GLU A 192 123.30 -37.71 REMARK 500 SER A 214 -77.42 -113.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L17 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF HIRUDIN IIIB' REMARK 999 REMARK 999 SEQUENCE REMARK 999 ACCORDING TO AUTHORS, HIRUGEN WAS CHEMICALLY SYNTHESIZED. DBREF 1Z71 A 1 246 UNP P00734 THRB_HUMAN 335 621 DBREF 1Z71 B 355 365 UNP P28511 ITHK_HIRME 55 65 SEQADV 1Z71 ALA B 365 UNP P28511 GLN 65 SEE REMARK 999 SEQRES 1 A 287 ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SER LEU SEQRES 2 A 287 GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER TYR ILE SEQRES 3 A 287 ASP GLY ARG ILE VAL GLU GLY SER ASP ALA GLU ILE GLY SEQRES 4 A 287 MET SER PRO TRP GLN VAL MET LEU PHE ARG LYS SER PRO SEQRES 5 A 287 GLN GLU LEU LEU CYS GLY ALA SER LEU ILE SER ASP ARG SEQRES 6 A 287 TRP VAL LEU THR ALA ALA HIS CYS LEU LEU TYR PRO PRO SEQRES 7 A 287 TRP ASP LYS ASN PHE THR GLU ASN ASP LEU LEU VAL ARG SEQRES 8 A 287 ILE GLY LYS HIS SER ARG THR ARG TYR GLU ARG ASN ILE SEQRES 9 A 287 GLU LYS ILE SER MET LEU GLU LYS ILE TYR ILE HIS PRO SEQRES 10 A 287 ARG TYR ASN TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA SEQRES 11 A 287 LEU MET LYS LEU LYS LYS PRO VAL ALA PHE SER ASP TYR SEQRES 12 A 287 ILE HIS PRO VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SEQRES 13 A 287 SER LEU LEU GLN ALA GLY TYR LYS GLY ARG VAL THR GLY SEQRES 14 A 287 TRP GLY ASN LEU LYS GLU THR TRP THR ALA ASN VAL GLY SEQRES 15 A 287 LYS GLY GLN PRO SER VAL LEU GLN VAL VAL ASN LEU PRO SEQRES 16 A 287 ILE VAL GLU ARG PRO VAL CYS LYS ASP SER THR ARG ILE SEQRES 17 A 287 ARG ILE THR ASP ASN MET PHE CYS ALA GLY TYR LYS PRO SEQRES 18 A 287 ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU GLY ASP SER SEQRES 19 A 287 GLY GLY PRO PHE VAL MET LYS SER PRO PHE ASN ASN ARG SEQRES 20 A 287 TRP TYR GLN MET GLY ILE VAL SER TRP GLY GLU GLY CYS SEQRES 21 A 287 ASP ARG ASP GLY LYS TYR GLY PHE TYR THR HIS VAL PHE SEQRES 22 A 287 ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE SEQRES 23 A 287 GLY SEQRES 1 B 11 ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU ALA MODRES 1Z71 TYS B 363 TYR O-SULFO-L-TYROSINE HET TYS B 363 16 HET L17 A1001 33 HETNAM TYS O-SULFO-L-TYROSINE HETNAM L17 L17 HETSYN L17 2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL) HETSYN 2 L17 ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3- HETSYN 3 L17 CHLOROPHENYL)ETHYL]ACETAMIDE FORMUL 2 TYS C9 H11 N O6 S FORMUL 3 L17 C22 H20 CL2 F2 N4 O3 FORMUL 4 HOH *194(H2 O) HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 2 THR A 14B TYR A 14J 1 9 HELIX 3 3 ALA A 55 CYS A 58 5 4 HELIX 4 4 PRO A 60B ASP A 60E 5 4 HELIX 5 5 THR A 60I ASN A 62 5 3 HELIX 6 6 ASP A 125 LEU A 130 1 9 HELIX 7 7 GLU A 164 SER A 171 1 8 HELIX 8 8 LYS A 185 GLY A 186C 5 5 HELIX 9 9 LEU A 234 GLY A 246 1 13 HELIX 10 10 PRO B 360 ALA B 365 1 6 SHEET 1 A 7 SER A 20 ASP A 21 0 SHEET 2 A 7 GLN A 156 PRO A 161 -1 O VAL A 157 N SER A 20 SHEET 3 A 7 LYS A 135 GLY A 140 -1 N GLY A 136 O LEU A 160 SHEET 4 A 7 PRO A 198 LYS A 202 -1 O VAL A 200 N ARG A 137 SHEET 5 A 7 TRP A 207 TRP A 215 -1 O TYR A 208 N MET A 201 SHEET 6 A 7 GLY A 226 HIS A 230 -1 O PHE A 227 N TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 N PHE A 181 O TYR A 228 SHEET 1 B 7 GLN A 30 ARG A 35 0 SHEET 2 B 7 GLU A 39 LEU A 46 -1 O CYS A 42 N LEU A 33 SHEET 3 B 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45 SHEET 4 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 B 7 LYS A 81 ILE A 90 -1 N GLU A 86 O LYS A 107 SHEET 6 B 7 LEU A 64 ILE A 68 -1 N VAL A 66 O SER A 83 SHEET 7 B 7 GLN A 30 ARG A 35 -1 N PHE A 34 O LEU A 65 SHEET 1 C 2 LEU A 60 TYR A 60A 0 SHEET 2 C 2 LYS A 60F ASN A 60G-1 O LYS A 60F N TYR A 60A SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.04 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.04 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.04 LINK C GLU B 362 N TYS B 363 1555 1555 1.33 LINK C TYS B 363 N LEU B 364 1555 1555 1.33 CISPEP 1 SER A 36A PRO A 37 0 0.03 SITE 1 AC1 19 HIS A 57 TYR A 60A TRP A 60D GLU A 97A SITE 2 AC1 19 ASN A 98 ILE A 174 ASP A 189 ALA A 190 SITE 3 AC1 19 CYS A 191 SER A 195 VAL A 213 SER A 214 SITE 4 AC1 19 TRP A 215 GLY A 216 GLU A 217 GLY A 219 SITE 5 AC1 19 GLY A 226 PHE A 227 HOH A1051 SITE 1 AC2 17 PHE A 34 GLU A 39 LEU A 40 LEU A 65 SITE 2 AC2 17 ARG A 73 THR A 74 ARG A 75 TYR A 76 SITE 3 AC2 17 GLU A 80 LYS A 81 ILE A 82 HOH A1060 SITE 4 AC2 17 HOH A1135 HOH A1175 HOH B 120 HOH B 130 SITE 5 AC2 17 HOH B 140 CRYST1 69.970 71.490 72.260 90.00 100.50 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014292 0.000000 0.002649 0.00000 SCALE2 0.000000 0.013988 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014075 0.00000